Sionna Therapeutics
BiotechnologyView the employees at
Sionna Therapeutics-
Alison Easter PhD, DABT Vice President of Preclinical Drug Safety at Sionna Therapeutics
-
Rising Star
Andy Chu BioPharma R&D Business and Technology Executive-
Cambridge, Massachusetts, United States
-
Top 5%
Mark M. Co-founder and Vice President of Medicinal Chemistry at Sionna Therapeutics-
Greater Boston
-
Top 1%
Mara Furlow Head, Global Regulatory Affairs and Quality-
Rising Star
Angelina Stoddard Accountant at Sionna Therapeutics-
Boston, Massachusetts, United States
-
Rising Star
Overview
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
-